Theodore George Drivas, MD, PhD

Keith W. Pratz, MD, based in Philadelphia, PA, is a highly regarded medical professional specializing in Medical Genetics, serving patients aged 4 to 65. He holds notable positions as the Deputy Director of the Abramson Cancer Center and the Pearl Basser Professor for BRCA-Related Research at the University of Pennsylvania. Dr. Pratz completed his medical education at the University of Pennsylvania School of Medicine and underwent residency at Beth Israel Deaconess Medical Center, followed by a fellowship at the Children's Hospital of Philadelphia. With an average patient rating of 4.8 out of 5, he is recognized for his compassionate care and expertise in genetics. Generated from the website

Dr. Nora Sandorfi, MD, is a Professor of Clinical Medicine in the Division of Rheumatology at the Perelman School of Medicine, University of Pennsylvania, with a special focus on Systemic Sclerosis (scleroderma) and Sjögren’s syndrome. She completed her medical training at Semmelweis University in Budapest, followed by residencies and fellowships in Philadelphia, including at Thomas Jefferson University Hospital. Over the past two decades, Dr. Sandorfi has served as Principal Investigator on numerous clinical trials and mentored rheumatology fellows in the scleroderma specialty clinic. Her commitment to patient education is also notable she regularly participates in outreach and educational events aimed at those living with scleroderma. Dr. Sandorfi is highly regarded for her deep clinical expertise, empathetic communication, and dedication to patient well-being. In her spare time, Dr. Sandorfi is an avid bicyclist.

The Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania is dedicated to advancing research that bridges the gap between basic science and clinical applications, focusing on the development of new and safer medicines. With an extensive network of over 2,500 investigators and partnerships with the Children's Hospital of Philadelphia and other notable institutions, ITMAT supports a comprehensive training platform for both researchers and support staff involved in translational medicine. Since its inception in January 2005, ITMAT has propelled the field of human phenomic science and enhanced collaborative interdisciplinary research through various funding initiatives and educational programs. The institute emphasizes bridging the pediatric to adult healthcare divide and integrates preclinical science with practical drug development, enriching the landscape of translational therapeutics. Generated from the website